Evaluation of in vitro antiviral activity of a brown alga (Cystoseira myrica) from the Persian Gulf against herpes simplex virus type 1

African Journal of Biotechnology

Volumn 6, Issue 22, 2007, Pages 2511-2514

  Zandi, Keivan ^a   Fouladvand, Moradali ^a   Pakdel, Parisa ^a   Sartavi, Kohzad ^b  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Jahad Keshavarzi Research Center   (Iran)

Author keywords

Antiviral; Cystoseira myrica; HSV 1; Persian Gulf

Indexed keywords

CYSTOSEIRA MYRICA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BROWN ALGA; CELL CULTURE; CONTROLLED STUDY; CYSTOSEIRA MYRICA; DRUG SCREENING; DRUG STABILITY; EVALUATION; HERPES SIMPLEX VIRUS 1; IC 50; IN VITRO STUDY; IRAN; NONHUMAN; VIRUS REPLICATION; VIRUS STRAIN;

ALGAE; CYSTOSEIRA MYRICA; HUMAN HERPESVIRUS 1; PHAEOPHYCEAE;

EID: 36448984372     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: 10.5897/ajb2007.000-2399     Document Type: Article

References (19)

1. Barbosa JP, Pereira RC, Abrantes JL, Cirne dos Santos CC, Rebello MA, Frugulhetti IC, Texeira VL (2004). In vitro antiviral diterpenes from the Brazilian brown alga Dictyota pfaffi. Plant Med. 70: 856-860.
2. Damonte EB, Matulewicz MC, Cerezo AS and Coto CE (1996). Herpes simplex Virus Sulfated xylogalactans from the red seaweed Nothogenia fastigiata. Chemotherapy 42: 57-64
3. Fields BN (2001) Fields Virology. Lippincott Raven Publisher, U. S. A.
4. Ghosh P, Adhikari U, Ghosal PK, Pujol CA, Carlucci MJ, Damonte EB, Ray B (2004). In vitro anti herpetic activity of sulfated polysaccharide fractions from Caulerpa racemsa. Phytochemistry 65: 3151-3157.
5. Hayashi K, Mori J, Saito H, Hayashi T (2006). Antiviral targets of a chromene derivative from Sargassum micracanthum in the replication of human cytomegalovirus. Biol. Pharm. Bull. 29: 1843-1847.
6. Kudi AC, Myrint SH (1999). Antiviral activities on some Nigerian medicinal plants extracts. J. Ethnopharmacol. 68: 289-294.
7. Kujumgier A, Tsevtkova I, Serkedjieva J, Bankova V, Christov R, Popov S (1999). Antibacterial, antifungal and antiviral activity of propolis of different geographic regions. J. Ethnopharmacol. 64: 235-240.
8. Lee JB, Hayashi K, Maeda M, Hayashi T (2004). Antiherpetic activity of sulfated polysaccharide from green algae. Planta. Med. 70: 813-817.
9. Lopez A, Hudsonb JB, Towers GH (2001). Antiviral and antimicrobial activities of Colombian medicinal plants. J. Ethnopharmacol. 77: 189-196.
10. Malvey D, Treilhaud, M, Bouee S, Crochard A, Vallee D, El Hasnaoui A, Aymard M (2005). A retrospective case control study of acyclovir resistance in herpes simplex virus. Clin. Infect. Dis. 41: 320-326.
11. Naesens L, De Clercq E (2001). Recent developments in herpes virus therapy. Herpes 8: 12-16.
12. Pottage JC, Kessler HA (1995). Herpes simplex virus resistance to acyclovir clinical relevance. Infect. Agents. Dis. 4: 115-124.
13. Preeprame S, Hayashi K, Lee JB, Sankawa K, Hayashi T (2001). A novel antivirally active fucan Sulfate derived from an edible brown alga, Sargassum horneri. Chem. Pharmacol. Bull. 49: 484-485.
14. Pujol CA, Scolaro LA, Ciancia M, Matulewicz MC, Cerezo AS, Damonte EB (2006). Antiviral activity of a carrageenan from Gigartina skottsbergii against intraperitoneal murine herpes simplex virus infection. Plant Med. 72: 121-125.
15. Richards JT, Kern ER, Glasgow LA, Overall JC, Deign EF, Melvin MT (1978). Antiviral activity of extracts from marine algae. Antimicrob. Agents. Chemotherapy 14: 24-30.
16. Rosen T (2006). Sexually transmitted diseases 2006: a dermatologist's view. Cleve. Clin. J. Med. 73: 537-538.
17. Serkedjieva J (2004). Antiviral activity of the red marine algae Ceramium rubrum. Phytother. Res. 18: 480-483.
18. Yoosook C, Panpisutchaia AY, Chaichanab S, Santisukc T, Reutrakulb V (1999). Evaluation of anti - HSV- 2 activities of Barleria lupulina and Clinacanthus nutans. J. Ethnopharmacol. 67: 179-187.
19. Zhu W, Chiu LC, Ooi VE, Chan PK, Ang PO (2004). Antiviral property and mode of action of a sulphated polysaccharide from Sargassum patens against herpes simplex virus type 2. Int. J. Antimicrob. Agents 24: 279-283.